IP Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 31

Professionals
  • Investments
  • 423

  • Portfolio
  • 123

  • Exits
  • 131

Exits

IP Group General Information

Description

Founded in 2001, IP Group is a venture capital firm based in London, United Kingdom. The firm seeks to invest in early-stage to mature businesses operating in the healthcare, life science, technology, cleantech, and biotechnology sectors.

Contact Information

Formerly Known As
IP2IPO Group
Year Founded
2001
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 2nd Floor, 3 Pancras Square
  • King's Cross
  • London N1C 4AG
  • England, United Kingdom
+44 020 0000 0000

IP Group Investments & Acquisitions (423)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Abliva 13-Jun-2022 PIPE 000.00 Pharmaceuticals Generating Revenue/Not Profitable
000 0000000000 26-May-2022 00000 00000 000.00 Agricultural Chemicals Generating Revenue
000000 03-May-2022 00000 00000 00.000 Pharmaceuticals Startup
000000 00000000000 02-May-2022 0000 00000 00.000 Drug Discovery Pre-Clinical Trials 0000 00000 00.0
00000000 28-Apr-2022 00000 00000 000.00 Business/Productivity Software Generating Revenue
00000000 11-Apr-2022 00000 00000 000.00 Therapeutic Devices Generating Revenue 000000 00000000 00.0
00000 000000000000 07-Apr-2022 00000 00000 00.000 Drug Discovery Pre-Clinical Trials 000000 000000000000 00.0
00000 15-Mar-2022 00000 00000 0000 Plastic Containers and Packaging Generating Revenue
Enterprise Therapeutics 09-Mar-2022 Later Stage VC 00.000 Drug Discovery Generating Revenue 00000 0000000000 00.0
Microbiotica 07-Mar-2022 Later Stage VC 0000 Biotechnology Generating Revenue 000000 00000000 00.0
You’re viewing 10 of 423 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IP Group Exits (131)

Company Name Exit Date Exit Type Exit Size
Augmented Bionics 12-Apr-2022 Out of Business
00000000 01-Jan-2022 000000000 00000000
00000000000 11-Oct-2021 000000000000000000 00.000
000000 00000000 00 30-Sep-2021 000 00000
00000000 14-Sep-2021 000 00 00000000
00000000 00000000 14-Sep-2021 000 00 00000000
00000000 00000000 17-Aug-2021 0000000000: 000000
00000000000 02-Jul-2021 000000000000000000
Structure Vision 01-Jul-2021 Secondary Transaction - Private
AVID Technology (Electrical Equipment) 30-Jun-2021 Merger/Acquisition
You’re viewing 10 of 131 exits. Get the full list »

IP Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore IP Group‘s full profile, request access.

Request a free trial

IP Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

IP Group Team (82)

Name Title Deals Funds Boards Office
Greg Smith Chief Executive Officer, Executive Director and Member of the Board of Directors 0 London, United Kingdom
Alan Aubrey Chief Executive Officer, Executive Director, and Member of the Board of Directors 00 0 0 London, United Kingdom
David Baynes Chief Operating Officer, Executive Director and Member of the Board of Directors 00 0 0 London, United Kingdom
Lewis Liu Ph.D Managing Director, Greater China & China Head, Cleantech 0 0 0 London, United Kingdom
Michael Molinari Ph.D Managing Director, Australia 0 0 London, United Kingdom
You’re viewing 5 of 82 team members. Get the full list »